
### [NCIT:C3738](http://purl.obolibrary.org/obo/NCIT_C3738)
**Label:** Osteoclastic Giant Cell-Rich Tumor of Bone

**Subclasses:** [NCIT:C121893](http://purl.obolibrary.org/obo/NCIT_C121893) (Giant Cell Lesion of Small Bones), [NCIT:C4304](http://purl.obolibrary.org/obo/NCIT_C4304) (Malignancy in Giant Cell Tumor of Bone), [NCIT:C27477](http://purl.obolibrary.org/obo/NCIT_C27477) (Benign Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C121933](http://purl.obolibrary.org/obo/NCIT_C121933) (Malignant Osteoclastic Giant Cell-Rich Tumor of Bone), [NCIT:C121932](http://purl.obolibrary.org/obo/NCIT_C121932) (Giant Cell Tumor of Bone), [NCIT:C121931](http://purl.obolibrary.org/obo/NCIT_C121931) (Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone), 

**Class expressions from DL-Learner:**

- Thing 52.53%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 40.36%
- [NCIT:C36827](http://purl.obolibrary.org/obo/NCIT_C36827) (Osteoclast-Like Giant Cell) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 40.36%


